Docs

A porcine-brain-derived peptide-and-amino-acid mixture studied in vitro and in preclinical models for neurotrophic and neuroprotective signaling.

A naturally occurring nonapeptide studied in preclinical models for delta-EEG, circadian, and neuroendocrine signaling.

A tuftsin-derived heptapeptide studied in vitro and in preclinical models for GABAergic, serotonergic, and neurotrophic signaling.

An ACTH(4-10)-derived heptapeptide studied in vitro for neurotrophic and neuromodulatory signaling without corticotropic activity.

A synthetic acetyl-octapeptide studied in cosmetic-science and neurotransmitter-release models for SNARE-complex modulation.

A Khavinson-class tripeptide bioregulator studied in vitro for gene-expression modulation and antioxidant signaling in neural cells.

A thymus-derived polypeptide fraction studied in vitro and in preclinical models for T-lymphocyte and cytokine-signaling modulation.

A C-terminal growth-hormone fragment studied in vitro and in preclinical models for adipocyte lipid-metabolism signaling without somatogenic activity.

A small-molecule NNMT inhibitor studied in vitro and in preclinical metabolic models for its effects on cellular NAD+ and methylation pools.

An acylated long-acting amylin analog studied in preclinical metabolic models for amylin- and calcitonin-receptor satiety signaling.

An oxyntomodulin-derived GLP-1/glucagon dual-agonist peptide studied in preclinical metabolic models for combined incretin and energy-expenditure signaling.

A GLP-1/GIP/glucagon triple-agonist peptide studied in preclinical metabolic models for combined incretin and energy-expenditure signaling.

An acylated GLP-1 receptor–agonist analog studied in preclinical metabolic models for incretin-pathway signaling.

A GIP/GLP-1 dual-agonist peptide studied in preclinical metabolic models for co-activation of both incretin receptors.

A synthetic small-molecule pan-agonist of the estrogen-related receptors studied in vitro and in preclinical models for oxidative-metabolism signaling.

A synthetic gastric-peptide fragment studied in vitro and in preclinical models for angiogenic and connective-tissue signaling.

A synthetic thymosin β-4 fragment studied in vitro and in preclinical models for actin-binding and cell-migration signaling.

A co-packaged BPC-157 and TB-500 pair supplied for combined-study designs in tissue-repair research.

A copper-binding tripeptide studied in vitro for extracellular-matrix and collagen-gene signaling in fibroblast culture.

An α-MSH C-terminal tripeptide studied in vitro and in preclinical models for anti-inflammatory NF-κB signaling.

A human cathelicidin-derived antimicrobial peptide studied in vitro for membrane-permeabilizing and immunomodulatory signaling.

An 11-amino-acid erythropoietin-derived peptide studied in vitro for innate-repair-receptor signaling distinct from the hematopoietic EPO pathway.

A co-formulated pair of growth-hormone-axis research peptides — a GHRH analog and a selective ghrelin-receptor secretagogue — supplied together for in-vitro and preclinical somatotroph-signaling studies.

A growth-hormone-releasing hexapeptide studied in vitro and in preclinical models as a ghrelin-receptor agonist driving somatotroph signaling.

A heterodimeric glycoprotein hormone studied in reproductive and endocrine research as an agonist at the luteinizing-hormone/choriogonadotropin receptor.

A long-acting IGF-1 analog studied in vitro and in preclinical models for IGF-1-receptor signaling and reduced binding-protein affinity.

A selective pentapeptide growth-hormone secretagogue studied in vitro and in preclinical models for receptor-selective somatotroph signaling.

A mitochondrial-derived peptide studied in vitro and in preclinical metabolic models as an AMPK-pathway activator.

A GHRH(1-29) analog studied in vitro and in preclinical models as a growth-hormone-releasing-hormone receptor agonist.

A stabilized GHRH(1-44) analog studied in vitro and in preclinical models as a growth-hormone-releasing-hormone receptor agonist.

An activin- and myostatin-binding glycoprotein studied in vitro and in preclinical models as a high-affinity antagonist of TGF-β-superfamily signaling.

A synthetic pineal-derived tetrapeptide (Ala-Glu-Asp-Gly) studied in vitro and in preclinical models for telomerase transcription and circadian gene regulation.

The endogenous tripeptide thiol antioxidant (γ-Glu-Cys-Gly), supplied as a research reagent and studied in vitro for redox-buffering and detoxification biochemistry.

A co-packaged research set of three connective-tissue peptides — GHK-Cu, BPC-157, and TB-500 — supplied together for in-vitro matrix, angiogenic, and cytoskeletal studies.

The pyridine-nucleotide coenzyme NAD+, supplied as a research reagent and studied in vitro for redox, sirtuin, and PARP-dependent biochemistry.

A mitochondria-targeted aromatic-cationic tetrapeptide (elamipretide) studied in vitro and preclinically for cardiolipin binding and electron-transport-chain support.

An acetylated 28-residue immunomodulatory peptide (prothymosin-α fragment) studied in vitro and preclinically for Toll-like-receptor signaling and T-cell maturation.

A co-packaged research set of four connective-tissue peptides — GHK-Cu, BPC-157, TB-500, and KPV — supplied together for in-vitro matrix, angiogenic, cytoskeletal, and anti-inflammatory studies.

The C-terminal decapeptide of the KISS1 gene product, studied in vitro and in preclinical models for KISS1R signaling within the hypothalamic reproductive axis.

A synthetic alpha-MSH analog with high melanocortin-1 receptor selectivity, studied in vitro and in preclinical models of melanocyte signaling and melanogenesis.

A cyclic alpha-MSH-analog heptapeptide and non-selective melanocortin-receptor agonist, studied in vitro and in preclinical models of melanocyte signaling and central melanocortin circuits.

A cyclic heptapeptide MC3R/MC4R agonist and metabolite of melanotan 2, studied in vitro and in preclinical models of central melanocortin signaling.

A 28-residue neuropeptide and VPAC-receptor agonist, studied in vitro and in preclinical models of circadian, immunomodulatory, and vascular signaling.

Sterile water with a benzyl-alcohol bacteriostatic preservative, used as the standard diluent for reconstituting lyophilized research peptides.